Boxer Capital’s Onconova Therapeutics, Inc. Warrants ONTXW Stock Holding History

Boxer Capital’s Portfolio ONTXW Stock Details ONTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-241,644	Closed	-$72K	–	33
2018 Q1	$72K	Hold	241,644	–	–	0.01%	33
2017 Q4	$133K	Sell	241,644 -67,149	-22%	-$39.8K	0.02%	26
2017 Q3	$528K	Buy	308,793 +67,149	+28%	+$36.1K	0.12%	29
2017 Q2	$109K	Hold	241,644	–	–	0.03%	27
2017 Q1	$202K	Hold	241,644	–	–	0.04%	31
2016 Q4	$150K	Hold	241,644	–	–	0.06%	28
2016 Q3	$242K	Buy	+241,644	New	+$256K	0.11%	27

Other funds holding ONTXW

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

TCP

Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Boxer Capital's ONTXW Position: Q2 2018 in Review

Boxer Capital sold out of Onconova Therapeutics, Inc. Warrants (ONTXW) in Q2 2018, closing a stake of 241,644 shares — an estimated $72K sold.

Boxer Capital first reported a position in ONTXW in Q3 2016 and held it in 7 quarters. The position peaked at $528K in Q3 2017. 4 funds tracked by Wall St. Rank hold ONTXW as of Q2 2018.

Boxer Capital reported no remaining Onconova Therapeutics, Inc. Warrants position as of Q2 2018 after selling out during the quarter.
Boxer Capital sold 241,644 Onconova Therapeutics, Inc. Warrants shares in Q2 2018, an estimated $72K.
Boxer Capital first reported a position in Onconova Therapeutics, Inc. Warrants in Q3 2016 and held it in 7 quarters.
Boxer Capital's Onconova Therapeutics, Inc. Warrants position peaked at $528K in Q3 2017.
4 funds tracked by Wall St. Rank held Onconova Therapeutics, Inc. Warrants as of Q2 2018.

Based on Boxer Capital's 13F filing for Q2 2018, filed 14 Aug 2018.